
Use of growth hormone therapy for osteoporosis in postmenopausal women: 10 year follow-up

Use of growth hormone therapy for osteoporosis in postmenopausal women: 10 year follow-up
Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study
J Clin Endocrinol Metab. 2015 Sep;100(9):3251-9Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Eighty postmenopausal women with osteoporosis were randomized to one of three treatment groups: one received 2.5 units of growth hormone per day for 3 years; one received 1 unit of growth hormone per day for 3 years; one received placebo every day for 18 months. The double-blind phase of the trial lasted up to 18 months. The purpose of the study was to evaluate the effects of growth hormone therap...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.